Cargando…
SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma
PURPOSE: Retinoblastoma (RB) is the most common primary intraocular tumor in children. Chemotherapy is currently the main method of RB treatment. Unfortunately, RB often becomes chemoresistant and turns lethal. Here, we used in vitro cell immunotherapy to explore whether adoptive immunotherapy could...
Autores principales: | Chen, Xuemei, Kunda, Patricia Elena, Lin, Jianwei, Zhou, Meiling, Huang, Jinghan, Zhang, Huqin, Liu, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843685/ https://www.ncbi.nlm.nih.gov/pubmed/29372378 http://dx.doi.org/10.1007/s00432-018-2584-x |
Ejemplares similares
-
Expression of Syk and MAP4 proteins in ovarian cancer
por: Zhang, Siwei, et al.
Publicado: (2019) -
p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapy
por: Lu, Chunwan, et al.
Publicado: (2020) -
TOSO interacts with SYK and enhances BCR pathway activation in chronic lymphocytic leukemia
por: Zhang, Yan-Ru, et al.
Publicado: (2020) -
Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma
por: Rohila, Deepak, et al.
Publicado: (2023) -
MiR-486-3p inhibits the proliferation, migration and invasion of retinoblastoma cells by targeting ECM1
por: Yang, Hongwei, et al.
Publicado: (2020)